AI-assisted, human-published
06/09/2025 /Funding Events
Mosanna Therapeutics Secures $80M in Series A Funding for Sleep Apnea Treatment
Mosanna Therapeutics secures $80 million in Series A funding to advance its lead therapy, MOS118, aimed at addressing obstructive sleep apnea (OSA) globally.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com